Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1 EUR
51.53 M EUR
100.51 M EUR
53.00 M
About PRO MEDICUS LIMITED
Sector
Industry
CEO
Sam Aaron Hupert
Website
Headquarters
Richmond
Founded
1983
ISIN
AU000000PME8
FIGI
BBG00GCTJN33
Pro Medicus Ltd. provides a range of radiology information technology software and services to hospitals, imaging centers and health care groups. It provides services in the form of installation and support. The firm offers a range of products including radiology information systems, picture archiving and communication systems. It also offers workflow mapping and optimization, network design and implementation, hardware sourcing, and configuration as well as staff and management training. The company was founded by Sam Aaron Hupert and Anthony Barry Hall in 1983 and is headquartered in Richmond, Australia.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PMC is 178 EUR — it has decreased by −3.26% in the past 24 hours. Watch PRO MEDICUS LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange PRO MEDICUS LTD. stocks are traded under the ticker PMC.
PMC stock has risen by 0.56% compared to the previous week, the month change is a 14.10% rise, over the last year PRO MEDICUS LTD. has showed a 217.86% increase.
We've gathered analysts' opinions on PRO MEDICUS LTD. future price: according to them, PMC price has a max estimate of 199.66 EUR and a min estimate of 99.83 EUR. Watch PMC chart and read a more detailed PRO MEDICUS LTD. stock forecast: see what analysts think of PRO MEDICUS LTD. and suggest that you do with its stocks.
PMC stock is 1.71% volatile and has beta coefficient of 1.82. Track PRO MEDICUS LTD. stock price on the chart and check out the list of the most volatile stocks — is PRO MEDICUS LTD. there?
Today PRO MEDICUS LTD. has the market capitalization of 18.21 B, it has increased by 0.11% over the last week.
Yes, you can track PRO MEDICUS LTD. financials in yearly and quarterly reports right on TradingView.
PRO MEDICUS LTD. is going to release the next earnings report on Aug 13, 2025. Keep track of upcoming events with our Earnings Calendar.
PMC earnings for the last half-year are 0.30 EUR per share, whereas the estimation was 0.29 EUR, resulting in a 0.60% surprise. The estimated earnings for the next half-year are 0.37 EUR per share. See more details about PRO MEDICUS LTD. earnings.
PRO MEDICUS LTD. revenue for the last half-year amounts to 58.09 M EUR, despite the estimated figure of 59.34 M EUR. In the next half-year revenue is expected to reach 72.29 M EUR.
PMC net income for the last half-year is 30.92 M EUR, while the previous report showed 28.97 M EUR of net income which accounts for 6.76% change. Track more PRO MEDICUS LTD. financial stats to get the full picture.
PRO MEDICUS LTD. dividend yield was 0.28% in 2024, and payout ratio reached 50.46%. The year before the numbers were 0.46% and 51.64% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PRO MEDICUS LTD. EBITDA is 83.97 M EUR, and current EBITDA margin is 74.77%. See more stats in PRO MEDICUS LTD. financial statements.
Like other stocks, PMC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PRO MEDICUS LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PRO MEDICUS LTD. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PRO MEDICUS LTD. stock shows the buy signal. See more of PRO MEDICUS LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.